-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Initiates Coverage On Amrize with Overweight Rating, Announces Price Target of $62

Benzinga·06/24/2025 13:14:03
Listen to the news
Morgan Stanley analyst Cedar Ekblom initiates coverage on Amrize (NYSE:AMRZ) with a Overweight rating and announces Price Target of $62.